Deborah M. Kurrasch-Orbaugh

Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).

D. E. Nichols, D. Marona-Lewicka, D. Kurrasch-Orbaugh, 2002, Journal of medicinal chemistry.

Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats

D. E. Nichols, D. Marona-Lewicka, D. Kurrasch-Orbaugh, 2002, Psychopharmacology.

A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases

V. Watts, D. Kurrasch-Orbaugh, D. Nichols, 2003, Journal of neurochemistry.

Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves

V. Watts, E. Barker, D. Kurrasch-Orbaugh, 2003, Journal of Pharmacology and Experimental Therapeutics.

Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists.

J. Chambers, M. Parker, D. Kurrasch-Orbaugh, 2001, Journal of medicinal chemistry.